[Form 4] EQUUS TOTAL RETURN, INC. Insider Trading Activity
Kenneth I. Denos, a director and the secretary of Equus Total Return, Inc. (EQS), received an award of 250,000 restricted shares on 09/16/2025 under the registrant's 2016 Equity Incentive Plan. The shares were awarded at an indicated price of $2.51 per share and increase Mr. Denos's beneficial ownership to 332,595 shares following the transaction. The filing notes that 250,000 of the shares are held directly by Acadia Law Group, P.C., a professional corporation beneficially owned and controlled by the reporting person who has execution authority on its behalf. The Form 4 is filed by one reporting person and is signed by Mr. Denos on the transaction date.
- None.
- None.
Insights
TL;DR: Routine equity award increases insider ownership; limited immediate market impact unless company is small or award is unusually large.
This restricted stock award of 250,000 shares to a director and officer aligns management and shareholder interests by increasing insider skin in the game. The filing shows an effective acquisition date of 09/16/2025 and a reported price of $2.51 per share, which appears to be the grant metric rather than an open-market purchase. The increase to 332,595 shares is material to the reporting individual's ownership but the Form 4 does not include company-wide share count or percent ownership, so assessing dilution or proportional impact on equity is not possible from this filing alone.
TL;DR: Standard equity compensation disclosure reflecting governance practice of compensating directors/officers via restricted stock grants.
The disclosure identifies Mr. Denos as both a director and secretary and documents the award as issued under the 2016 Equity Incentive Plan, consistent with typical director/officer compensation policies. The note that shares are held by Acadia Law Group, P.C., controlled by the reporting person, clarifies indirect vs direct ownership. There is no indication of related-party concerns or unusual vesting terms in this filing; absent additional plan or company-level context, this appears to be a routine, governance-compliant grant.